Rafarma Pharmaceuticals (Laskavy Patent) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Rafarma Pharmaceuticals (Laskavy Patent) General Information
Description
Portfolio of medicinal patent right in the United States. The asset offers the company access to several new technologies including the new generation immune modulator XR.
Contact Information
Corporate Office
- United States
Corporate Office
- United States
Rafarma Pharmaceuticals (Laskavy Patent) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Rafarma Pharmaceuticals (Laskavy Patent) FAQs
-
Where is Rafarma Pharmaceuticals (Laskavy Patent) headquartered?
Rafarma Pharmaceuticals (Laskavy Patent) is headquartered in .
-
What industry is Rafarma Pharmaceuticals (Laskavy Patent) in?
Rafarma Pharmaceuticals (Laskavy Patent)’s primary industry is Buildings and Property.
-
Is Rafarma Pharmaceuticals (Laskavy Patent) a private or public company?
Rafarma Pharmaceuticals (Laskavy Patent) is a Private company.
-
What is Rafarma Pharmaceuticals (Laskavy Patent)’s current revenue?
The current revenue for Rafarma Pharmaceuticals (Laskavy Patent) is
. -
When was Rafarma Pharmaceuticals (Laskavy Patent) acquired?
Rafarma Pharmaceuticals (Laskavy Patent) was acquired on 16-Apr-2020.
-
Who acquired Rafarma Pharmaceuticals (Laskavy Patent)?
Rafarma Pharmaceuticals (Laskavy Patent) was acquired by Rafarma Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »